[A controlled study on the effects of nomifensine treatment of depression in the elderly]. 1983

P Miotto, and L Allegro, and G Ziliotto

After a description of the pharmacological and therapeutic properties of Nomifensine, the results obtained by administering the drug to 40 elderly patients suffering from depression are reported. A double blind test with a placebo was conducted in two separate stages. Dosage was 70-75 mg per diem. Effects were evaluated on a slightly modified Plutchik scale. The drug alleviated depressive symptoms to a statistically significant greater degree than the placebo. Subjective side effects were minimal. No A.P. or biohumoral changes were observed.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009627 Nomifensine An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266) Hoe-984,Linamiphen,Merital,Nomifensin,Nomifensine Maleate,Nomifensine Maleate (1:1),Hoe 984,Hoe984,Maleate, Nomifensine
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Miotto, and L Allegro, and G Ziliotto
January 1979, Rivista di patologia nervosa e mentale,
P Miotto, and L Allegro, and G Ziliotto
January 1977, British journal of clinical pharmacology,
P Miotto, and L Allegro, and G Ziliotto
January 1979, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
P Miotto, and L Allegro, and G Ziliotto
April 1984, The Journal of clinical psychiatry,
P Miotto, and L Allegro, and G Ziliotto
July 1986, International clinical psychopharmacology,
P Miotto, and L Allegro, and G Ziliotto
June 2001, International psychogeriatrics,
P Miotto, and L Allegro, and G Ziliotto
January 1982, Advances in biochemical psychopharmacology,
P Miotto, and L Allegro, and G Ziliotto
July 1985, British medical journal (Clinical research ed.),
P Miotto, and L Allegro, and G Ziliotto
March 1981, Acta psychiatrica Scandinavica,
P Miotto, and L Allegro, and G Ziliotto
May 2024, Complementary therapies in medicine,
Copied contents to your clipboard!